Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.

News & Updates

Safety at VIVA and The VEINS 2021

June 1, 2021

Reflecting on the past year, VIVA and The VEINS remain mindful of the ongoing effects of COVID-19. As in-person meetings and activities slowly resume, VIVA is committed, to the extent possible, to providing a safe environment to attendees, faculty, exhibitors and staff. Las Vegas is taking steps toward a full reopening ...

News & Updates

The VEINS Announces 2021-22 Scientific Committee

March 11, 2021

VIVA Physicians is pleased to announce four new appointments to the Scientific Committee for The VEINS at VIVA. Serving a two-year term, this multidisciplinary group of experts will work with Course Director Maureen Kohi, MD, to develop comprehensive, novel, and balanced curricula for today's venous specialists. Now i ...

News & Updates

The VEINS 2020 Preview

November 14, 2020

Raghu Kolluri, MS, MD VIVA Board of Directors | The VEINS Course Director For 10 years, The VEINS has met its mission of providing unparalleled venous education. Annually, the conference has expanded and adapted to reach an ever-growing audience of healthcare providers, both in numbers and the diversity of specialties ...

News & Updates

4-Year DCB Mortality Across ILLUMENATE RCTs

November 7, 2020

Presented by Sean Lyden, MD The Stellarex (Philips) drug-coated balloon (DCB) is a unique low-dose 2mcg/dl paclitaxel-coated balloon using polyethylene glycol as an excipient. The Stellarex DCB has been studied in 7 above-the-knee popliteal studies in over 2900 patients treated with independent clinical event committe ...

News & Updates

2-Year Outcomes of a Multi-Centre Study on Infrapopliteal Bioresorbable Vascular Scaffold

November 7, 2020

Presented by Steven Kum, MD Chronic Limb Threatening Ischemia (CLTI) continues to plague many patients worldwide and is associated with complex comorbidities, poor vessel patency, and major lower extremity amputations. Plain balloon angioplasty is still the mainstay of treatment although metallic drug-eluting stents h ...

Load More